Osimertinib
ATC L01EB04 · 11 markets · 29 records
CN 8 records · 2 strengths
US 4 records · 2 strengths
GB 4 records · 2 strengths
CA 2 records · 2 strengths
AU 2 records · 2 strengths
SG 2 records · 2 strengths
ES 2 records · 2 strengths
HK 2 records · 1 strengths
Records without a stated strength · 1 TAGRISSO
TW 1 records · 1 strengths
- 80 mgtabletTAGRISSO泰格莎膜衣錠80毫克
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 TAGRISSO
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|---|
| 80 mg tablet | TAGRISSO | TAGRISSO | TAGRISSO | TAGRISSO | TAGRISSO | 泰瑞沙奥希替尼 | TAGRISSO | TAGRISSO 泰格莎膜衣錠80毫克 | ||
| 40 mg tablet | TAGRISSO | TAGRISSO | TAGRISSO | TAGRISSO | TAGRISSO | 泰瑞沙奥希替尼 | TAGRISSO | |||
unknown | TAGRISSO | TAGRISSO |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in HK · EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en HK · EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 HK · EU 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 HK · EU 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.